Pegfilgrastim (drug)

DRUG2 trials

Sponsors

University Hospital, Clermont-Ferrand, TORL Biotherapeutics, LLC

Conditions

Endometrioid Ovarian CancerEpithelial Ovarian CancerFallopian Tube CancerPrimary PeritonealSolid Malignancies

Phase 2

Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children

TerminatedNCT00695370

University Hospital, Clermont-FerrandSolid Malignancies

Start: 2006-01-31End: 2008-01-31Target: 30Updated: 2008-06-13

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

RecruitingNCT06690775

TORL Biotherapeutics, LLCEndometrioid Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer +1

Start: 2024-11-20End: 2027-12-31Target: 230Updated: 2025-12-23